Directory
>
Neal Flomenberg
Neal Flomenberg
Chief Scientific Officer | TEVOGEN BIO
Philadelphia, Pennsylvania, United States
Neal Flomenberg
Summary
Neal Flomenberg is a seasoned Chief Scientific Officer at Tevogen Bio, Inc., where he is at the forefront of utilizing Cytotoxic T Lymphocytes to combat viral diseases and cancers. With extensive experience in the academic and research sectors, he previously held significant leadership roles at Thomas Jefferson University, including Chairman of the Department of Medical Oncology and Deputy Director of the Sidney Kimmel Cancer Center. His career spans several decades, showcasing a deep commitment to advancing medical science and innovative cancer therapies. Neal's work is characterized by a blend of scientific rigor and visionary leadership, making him a prominent figure in the field of oncology. His strategic insights and collaborative approach have driven impactful research initiatives. Passionate about translating scientific discoveries into clinical applications, Neal continues to influence the future of cancer treatment.
Neal Flomenberg
Work Experience
Chief Scientific Officer at
TEVOGEN BIO
July 2022 - Present
Chairman, Department of Medical Oncology; Deputy Director, Sidney Kimmel Cancer Center at
Jefferson University Physicians
July 1976 - August 2022
Frequently Asked Questions about Neal Flomenberg
What is Neal Flomenberg email address?
Neal Flomenberg's primary email address is ***************@tevogen.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Neal Flomenberg work for?
Neal Flomenberg is a Chief Scientific Officer at TEVOGEN BIO, a company specializing in Commercial physical research.
How can I directly contact Neal Flomenberg?
To contact Neal Flomenberg directly, you can use the email address ***************@tevogen.com. Complete contact information is available upon registration with Muraena.
Who is Neal Flomenberg?
Neal Flomenberg is a seasoned Chief Scientific Officer at Tevogen Bio, Inc., where he is at the forefront of utilizing Cytotoxic T Lymphocytes to combat viral diseases and cancers. With extensive experience in the academic and research sectors, he previously held significant leadership roles at Thomas Jefferson University, including Chairman of the Department of Medical Oncology and Deputy Director of the Sidney Kimmel Cancer Center. His career spans several decades, showcasing a deep commitment to advancing medical science and innovative cancer therapies. Neal's work is characterized by a blend of scientific rigor and visionary leadership, making him a prominent figure in the field of oncology. His strategic insights and collaborative approach have driven impactful research initiatives. Passionate about translating scientific discoveries into clinical applications, Neal continues to influence the future of cancer treatment.
Neal`s contact details
***************@tevogen.com
***********@kimmelcancercenter.org
***************@jefferson.edu
Colleagues
Chair and Chief Executive Officer
Chief Commercial Officer
CIO & Head Tevogen AI
Chief Technical Officer